Vical Inc - Company & Market Research Reports

Vical Incorporated is a biopharmaceutical company that develops products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Its product candidates include CyMVectin prophylactic vaccine for cytomegalovirus (CMV), a therapeutic vaccine and prophylactic for herpes simplex virus type 2 and VL-2397 antifungal. The company was founded in 1987 and is headquartered in San Diego, California.

From
From
From
Dengue DNA vaccine - Product Thumbnail Image

Dengue DNA vaccine

  • Drug Pipelines
  • 10 Pages
From
From
From
From
From
Genital Herpes - Pipeline Review, H2 2018 - Product Thumbnail Image

Genital Herpes - Pipeline Review, H2 2018

  • Drug Pipelines
  • 83 Pages
From
Hepatitis B - Pipeline Review, H1 2018 - Product Thumbnail Image

Hepatitis B - Pipeline Review, H1 2018

  • Drug Pipelines
  • 365 Pages
From
Genital Herpes - Pipeline Review, H1 2018 - Product Thumbnail Image

Genital Herpes - Pipeline Review, H1 2018

  • Drug Pipelines
  • 88 Pages
From
From
From
From
From
From
From
From
Aspergillosis - Pipeline Review, H2 2018 - Product Thumbnail Image

Aspergillosis - Pipeline Review, H2 2018

  • Drug Pipelines
  • 140 Pages
From
Loading Indicator
adroll